Moisture Milk Base

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

Glycerin fills a polyol-humectant role in the listed cosmetic formats. Read its percentage as formulation guidance, not an assay.

3. Typical use levels (formulation guide)

• Gels and serums: 3–8%.
• 2–5% is listed for creams in this reference.
• For rinse-off, use 2–4%.

The guide places Glycerin in the water phase and calls for no melt step.

4. Regulatory sources & global compliance

• Treat any CosIng entry for Glycerin as a reference only; verify the grade and intended use under current market rules.
• Before EU placement, Regulation (EC) No 1223/2009 requires the final cosmetic with Glycerin to undergo a safety assessment as a finished-product assessment.
• Confirm the actual Glycerin grade from supplier documentation and check requirements where the product will be sold.

5. Safety & risk assessment

The guide records a level for cosmetic formulation purposes; this reference is not approval for drug use or OTC marketing and the final formula should undergo patch and stability assessment.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; match the pack choice to the system's oxidation risk; use batch testing to verify stability and package compatibility.

7. Claims language (Do / Don’t)

• For cosmetic use, this entry records Glycerin in a direction centered on humectant function.

• The available ingredient details provides no basis for drug claims, cure claims, or a certification that is absent from the product records.
• This guide to Glycerin does not confirm whitening, treatment of acne, perspiration control, sun protection, or hair growth.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

Squalane provides the referenced hydrocarbon-emollient role in a plant-derived grade; mineral oil is not part of this guide.

3. Typical use levels (formulation guide)

• For gel-creams, use 2–6% as a formulation guide.
• The guide range for dry oils is 10–30% in this reference.
• The stated reference for balms is 5–15%.

The oil phase is the addition point for Squalane, with no high-shear wax operation.

4. Regulatory sources & global compliance

• Database information on Squalane does not replace review of the supplied grade and finished product under market rules.
• For an EU-market product, Regulation (EC) No 1223/2009 requires a safety review of the finished cosmetic in which Squalane is used as part of the finished cosmetic's safety documentation.
• Establish grade-specific details for Squalane from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; the note establishes neither drug approval nor OTC-monograph status with patch response and finished-product stability still to be verified.

6. Stability & packaging

Use cool, sealed storage away from strong light for the bulk; evaluate packaging against the formula's susceptibility to oxidation; follow with stability and packaging checks on the confirmed batch.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Squalane centers on a light-emollient role.

• The development record cannot verify a drug effect, a clinical cure, or certification status not established for the SKU.
• The available details for Squalane is not evidence for whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI & CAS

INCI: Caprylic/Capric Triglyceride · CAS: 73398-61-5

2. Role in the formula

Lotions, balms, and cleansing oils are the formats where this guide assigns caprylic/capric triglyceride a light-oil role.

3. Typical use levels (formulation guide)

• For lotions, use 3–8% in this reference.
• The formulation record indicates 20–60% for cleansing oils and balms as a formulation guide.

Route Caprylic/Capric Triglyceride through the oil phase.

4. Regulatory sources & global compliance

• CosIng information about Caprylic/Capric Triglyceride does not itself authorize a particular grade or finished cosmetic.
• The finished-product provisions of Regulation (EC) No 1223/2009 require an assessment addressing the safety of the finished product that contains Caprylic/Capric Triglyceride before the cosmetic is placed on the EU market.
• Verify the purchased Caprylic/Capric Triglyceride grade using supplier data, alongside the applicable filing rules for the destination market.

5. Safety & risk assessment

The use-level note is a reference for cosmetic formulation; it does not establish drug approval or OTC-monograph status while finished-product patch and stability testing remain necessary.

6. Stability & packaging

Keep the ingredient in cool, closed bulk storage away from sunlight; where oxidation is a concern, evaluate airless or pump packaging; check the finished formula and its packaging together.

7. Claims language (Do / Don’t)

• The formulation note describes Caprylic/Capric Triglyceride as part of a cosmetic direction focused on light-triglyceride.

• The development record does not support therapeutic effects, curative outcomes, or unsupported certification statements.
• The Caprylic/Capric Triglyceride entry cannot verify whitening, treatment of acne, perspiration control, sun protection, or hair growth.